4H-吡喃-4-酮,2-氯-6-(4-吗啉基)- | 119671-47-5

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 4H-吡喃-4-酮,2-氯-6-(4-吗啉基)-
• 英文名称: 6-chloro-2-(4-morpholin-4-yl)pyran-4-one
• 英文别名: 2-chloro-6-morpholino-4H-pyran-4-one；2-chloro-6-morpholino-pyran-4-one；2-chloro-6-morpholin-4-yl-pyran-4-one；2-chloro-6-morpholin-4-ylpyran-4-one
• CAS: 119671-47-5
• 化学式: C₉H₁₀ClNO₃
• 分子量: 215.636
• InChiKey: QGZKNCBYDQXMQU-UHFFFAOYSA-N

物化性质

• 熔点：
  100 - 103°C
• 沸点：
  373.2±42.0 °C(Predicted)
• 密度：
  1.39±0.1 g/cm3(Predicted)
• 溶解度：
  乙腈（微溶）、氯仿（微溶）、DMSO（微溶）、甲醇（微溶）

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  38.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4H-吡喃-4-酮,2-氯-6-(4-吗啉基)- 在 高氯酸 作用下， 生成 4-Hydroxy-2,6-di-morpholin-4-yl-pyranylium; perchlorate
  参考文献：
  名称：

  2,4,6-三（二烷基氨基）吡啶鎓盐及相关体系，合成与反应行为

  摘要：

  2,4,6-三（二烷基氨基）吡喃鎓盐和2,6-二（二烷基氨基）-2H-吡喃-4-酮以及它们的硫代类似物，已制备了通过启动1,1,5-多步途径，5-四氯戊-1,4-二烯-3-酮（）。（二烷基氨基） -取代的三，经历亲电取代。它们可以更好地表示为类似聚次甲基的系统。2,6-双（二烷基氨基）-取代的，在羰基氧上显示出显着增加的供体反应性。

  DOI：

  10.1016/s0040-4039(00)80583-3
• 作为产物：
  描述：

  4-chloro-4-(2,2,2-trichloroethyl)-oxetan-2-one 在 高氯酸 、 碳酸氢钠 作用下， 以 1,4-二氧六环 、 二氯甲烷 为溶剂， 反应 3.33h， 生成 4H-吡喃-4-酮,2-氯-6-(4-吗啉基)-
  参考文献：
  名称：

  Pyranone, Thiopyranone, and Pyridone Inhibitors of Phosphatidylinositol 3-Kinase Related Kinases. Structure−Activity Relationships for DNA-Dependent Protein Kinase Inhibition, and Identification of the First Potent and Selective Inhibitor of the Ataxia Telangiectasia Mutated Kinase

  摘要：

  Structure-activity relationships have been investigated for inhibition of DNA-dependent protein kinase (DNA-PK) and ATM kinase by a series of pyran-2-ones, pyran-4-ones, thiopyran-4-ones, and pyridin-4-ones. A wide range of IC50 values were observed for pyranones and thiopyranones substituted at the 6-position, with the 3- and 5-positions proving intolerant to substitution. Related pyran-2-ones, pyran-4-ones, and thiopyran-4-ones showed similar IC50 values against DNA-PK, whereas the pyridin-4-one system proved, in general, ineffective at inhibiting DNA-PK. Extended libraries exploring the 6-position of 2-morpholino-pyran-4-ones and 2-morpholino-thiopyrano-4-ones identified the first highly potent and selective ATM inhibitor 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one (151C; ATM; IC50 = 13 nM) and revealed constrained SARs for ATM inhibition compared with DNA-PK. One of the most potent DNA-PK inhibitors identified, 2-(4-methoxyphenyl)-6-(morpholin-4-yl)pyran-4-one (16; DNA-PK; IC50 = 220 nM) effectively sensitized HeLa cells to the topoisomerase II inhibitor etoposide in vitro.

  DOI：

  10.1021/jm061121y

文献信息

• NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF
  申请人：FUJIFILM Corporation

  公开号：US20160168139A1

  公开（公告）日：2016-06-16

  There is provided a morpholine derivative represented by General Formula [1A] or a salt thereof. (In the formula, a ring A represents a ring represented by General Formula [I]; * represents a bonding position; Z 2 represents CH or the like; Z 1 represents CR 6 or the like; R 6 represents a hydrogen atom or the like; X 1 represents CHR 7 or the like; R 7 represents a hydrogen atom or the like; X 2 represents CH 2 or the like; R 1 and R 2 are the same as or different from each other, and each of R 1 and R 2 represents a hydrogen atom or the like; R 3 , R 4 , and R 5 are the same as or different from each other, and each of R 3 , R 4 , and R 5 represents a hydrogen atom, NR a R b , or the like; and each of R a and R b represents a hydrogen atom, a C 1-8 alkyl group which may have a substituent, or the like.)

  提供一种由通用式[1A]表示的吗啉衍生物或其盐。 （在该式中，环A代表由通用式[I]表示的环；*代表连接位置；Z 2 代表CH或类似物；Z 1 代表CR 6 或类似物；R 6 代表氢原子或类似物；X 1 代表CHR 7 或类似物；R 7 代表氢原子或类似物；X 2 代表CH 2 或类似物；R 1 和R 2 相同或不同，且R 1 和R 2 中的每一个代表氢原子或类似物；R 3 ，R 4 和R 5 相同或不同，且R 3 ，R 4 和R 5 中的每一个代表氢原子，NR a R b 或类似物；R a 和R b 中的每一个代表氢原子，可能具有取代基的C 1-8 烷基基团，或类似物。）
• ATM inhibitors
  申请人：Kudos Pharmaceuticals Ltd

  公开号：US20040002492A1

  公开（公告）日：2004-01-01

  The application concerns a compound of formula I: 1 wherein one of P and Q is O, and the other of P and Q is CH, where there is a double bond between whichever of Q and P is CH and the carbon atom bearing the R 3 group; Y is either O or S; R 1 and R 2 are independently hydrogen, an optionally substituted C 1-7 alkyl group, C 3-20 heterocyclyl group, or C 5-20 aryl group, or may together form an optionally substituted heterocyclic ring having from 4 to 8 ring atoms; R 3 is a phenyl or pyridyl group, attached by a first bridge group selected from —S—, —S(═O)—, —S(═O) 2 —, —O—, —NR N — and CR C1 R C2 — to an optionally substituted C 5-20 carboaryl group, the phenyl or pyridyl group and optionally substituted C 5-20 carboaryl group being optionally further linked by a second bridge group, so as to form an optionally substituted C 5-7 ring, the phenyl or pyridyl group being further optionally substituted.

  该应用涉及一种具有以下式I的化合物：其中P和Q中的一个是O，另一个是CH，Q和P中的CH之一之间存在双键，并且带有R3基团的碳原子；Y可以是O或S；R1和R2独立地是氢、可选择地取代的C1-7烷基、C3-20杂环基团或C5-20芳基，或者可以一起形成具有4至8个环原子的可选择地取代的杂环环；R3是苯基或吡啶基团，通过第一桥基团连接到一个可选择地取代的C5-20碳芳基团，该苯基或吡啶基团和可选择地取代的C5-20碳芳基团可以进一步通过第二桥基团连接，从而形成一个可选择地取代的C5-7环，苯基或吡啶基团可以进一步选择性地取代。
• [EN] AMINOPYRONES AND THEIR USE AS ATM INHIBITORS<br/>[FR] AMINOPYRONES ET LEUR UTILISATION EN TANT QU'INHIBITEURS D'ATM
  申请人：KUDOS PHARM LTD

  公开号：WO2005016919A1

  公开（公告）日：2005-02-24

  Compounds of formula (I) wherein R1 and R2 together form, along with the nitrogen atom to which they are attached, an optionally substituted heterocyclic ring, X is S, NR’’ or CH2, R and R’ are hydrogen or specified substituents, and R’’ is a specified substituent, are useful as inhibitors of the kinase ATM (ataxia-telangiectasia mutated), particularly in the treatment of cancer and retroviral mediated diseases.

  具有式（I）的化合物，其中R1和R2与它们连接的氮原子一起形成一个可选择取代的杂环环，X为S、NR’’或CH2，R和R’为氢或指定的取代基，R’’为一个指定的取代基，可用作激酶ATM（共济失调-毛细血管扩张性疾病突变）的抑制剂，特别是在癌症和逆转录病原体介导的疾病的治疗中。
• ATM INHIBITOR
  申请人：Smith Cameron Murray Graeme

  公开号：US20070049588A1

  公开（公告）日：2007-03-01

  A compound of formula (I): and isomers, salts, solvates, chemically protected forms, and prodrugs thereof, and their use in treating diseases ameliorated by the inhibition of ATM.

  公式(I)的化合物及其异构体、盐、溶剂合物、化学保护形式和前药，以及它们在治疗通过抑制ATM改善的疾病中的用途。
• [EN] PYRANONES USEFUL AS ATM INHIBITORS<br/>[FR] PYRANONES UTILES COMME INHIBITEURS DE L'ATM
  申请人：KUDOS PHARM LTD

  公开号：WO2003070726A1

  公开（公告）日：2003-08-28

  The application concerns a compound of formula I: (I) wherein one of P and Q is O, and the other of P and Q is H, where there is a double bond between whichever of Q and P is CH and the carbon atom bearing the R3 group;Y is either O or S;R1 and R2 are independently hydrogen, an optionally substituted C1-7 alkyl group, C3-20 heterocyclyl group, or C5-20 aryl group, or may together form an optionally substituted heterocyclic ring having from 4 to 8 ring atoms;R3 is a phenyl or pyridyl group, attached by a first bridge group selected from -S-, -S (=O)-, -S(=O)2-, -O-, -NRN- and CRC1RC2- to an optionally substituted C5-20 carboaryl group, the phenyl or pyridyl group and optionally substituted C5-20 carboaryl group being optionally further linked by a second bridge group, so as to form an optionally substituted C5-7 ring, the phenyl or pyridyl group being further optionally substituted.

  该应用涉及一种具有化学式I的化合物：（I）其中P和Q中的一个是O，另一个是H，在Q和P中的哪一个是CH和带有R3基团的碳原子之间存在双键；Y可以是O或S；R1和R2独立地是氢，可选的取代C1-7烷基，C3-20杂环基团或C5-20芳基团，或者可以共同形成具有4至8个环原子的可选取代杂环环；R3是连接到可选取代的C5-20碳基芳基基团的苯基或吡啶基团，该苯基或吡啶基团通过第一桥基团（选自-S-，-S（=O）-，-S（=O）2-，-O-，-NRN-和CRC1RC2-）连接，苯基或吡啶基团和可选取代的C5-20碳基芳基基团可以通过第二桥基团进一步连接，以形成可选取代的C5-7环，苯基或吡啶基团可以进一步取代。